Volume : 6, Issue : 7, July - 2017

An experience of Postpartum Intrauterine contraceptive device by women - A prospective follow up study

Urvashi Barman Singh, Shweta Patel, Shubhangi, Meena Dayal

Abstract :

<p>&nbsp;<b style="text-align: justify;"><span lang="EN-IN" style="font-size:12.0pt;&#10;line-height:150%;font-family:&quot;Times New Roman&quot;,serif">Background: S</span></b><span lang="EN-IN" style="text-align: justify; font-size: 12pt; line-height: 150%; font-family: &quot;Times New Roman&quot;, serif;">tudy was done to assess the safety, efficacy, complications and acceptance of PPIUCD. </span><b style="text-align: justify;"><span lang="EN-IN" style="font-size:12.0pt;line-height:150%;font-family:&#10;&quot;Times New Roman&quot;,serif">Methods:</span></b><span lang="EN-IN" style="text-align: justify; font-size: 12pt; line-height: 150%; font-family: &quot;Times New Roman&quot;, serif;"> 673 enrolled women were divided into two groups. Cu-T 380 A was inserted in both the groups. Postplacental group included 271 cases and Intracaesarean group 402 cases. There were three follow up visits - at 6 weeks, after 3 months and at 6 months postpartum. <b>Results: </b>The continuation rate was 82.28% in postplacental group and 89.8% in intracaesarean group.<b> </b></span><span lang="EN-IN" style="text-align: justify; font-size: 12pt; line-height: 150%; font-family: &quot;Times New Roman&quot;, serif;">Most common complication was expulsion in both the group. Intracaesarean insertion group was having missing thread as second most common complication while bleeding p/v was in </span><span lang="EN-IN" style="text-align: justify; font-size: 12pt; line-height: 150%; font-family: &quot;Times New Roman&quot;, serif;">postplacental group.</span><span lang="EN-IN" style="text-align: justify; font-size: 12pt; line-height: 150%; font-family: &quot;Times New Roman&quot;, serif;"> Cause of removal was mainly bleeding 9(64.26%) in Intracaesarean group and pain in lower abdomen 8(32%) in &nbsp;Postplacental group. <b>Conclusions: </b>I</span><span lang="EN-IN" style="text-align: justify; font-size: 12pt; line-height: 150%; font-family: &quot;Times New Roman&quot;, serif;">nsertion of Cu T immediately following delivery is an effective, safe, convenient, low cost and long term method of postpartum contraception irrespective of the mode of delivery.&nbsp;</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:6.0pt;&#10;margin-left:0in;text-align:justify;line-height:150%;page-eak-after:avoid"><span lang="EN-IN" style="font-size:12.0pt;&#10;line-height:150%;font-family:&quot;Times New Roman&quot;,serif;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;"><o:p></o:p></span></p>